Mahmoudreza Moein1, Melanie Tacher Otero1, Gavrielle J Rood1, Matthew Hanlon1, Reza Saidi2. 1. Division of Transplant Services, Department of Surgery, SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY, 13210, USA. 2. Division of Transplant Services, Department of Surgery, SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY, 13210, USA. SaidiR@upstate.edu.
Abstract
INTRODUCTION: Kidney transplantation (KT) is the gold standard treatment for end-stage renal disease (ESRD) patients. Obesity is a strong risk factor for developing cardiovascular disease, chronic kidney disease, and ESRD. This study aimed to investigate the outcomes of kidney transplantation in obese recipients. MATERIAL AND METHODS: We retrospectively reviewed the medical records of recipients from January 2016 to December 2021 in a single center. Outcomes in recipients of a kidney allograft with BMI ≥ 30 were compared with the outcomes in recipients with 30 < BMI. RESULTS: A total of 467 consecutive kidney transplantation recipients' files were studied. 213 (45.6%) allograft recipients had a BMI ≥ 30, and 254 (54.4%) allograft recipients had a BMI < 30. DGF rate was 29.1% in the BMI ≥ 30 and 30.7% in the BMI < 30 group (P = 0.41). On the other hand, 30 days readmission rate also did not show a significant difference between the BMI ≥ 30 and BMI < 30 allograft recipients (37 vs. 33.8%, P = 0.46). The mean overall costs of transplantation in the BMI ≥ 30 group was $254,395, and it was $256,029 in the BMI < 30 group (P = 0.84). CONCLUSION: Our study shows that the outcomes of renal allograft transplant were comparable between recipients with BMI ≥ 30 and BMI < 30 in terms of DGF, LOS, 30 days readmission, acute rejection rate, and survival rates, and BMI should not be a single independent criterion for decision making to select an optimal recipient.
INTRODUCTION: Kidney transplantation (KT) is the gold standard treatment for end-stage renal disease (ESRD) patients. Obesity is a strong risk factor for developing cardiovascular disease, chronic kidney disease, and ESRD. This study aimed to investigate the outcomes of kidney transplantation in obese recipients. MATERIAL AND METHODS: We retrospectively reviewed the medical records of recipients from January 2016 to December 2021 in a single center. Outcomes in recipients of a kidney allograft with BMI ≥ 30 were compared with the outcomes in recipients with 30 < BMI. RESULTS: A total of 467 consecutive kidney transplantation recipients' files were studied. 213 (45.6%) allograft recipients had a BMI ≥ 30, and 254 (54.4%) allograft recipients had a BMI < 30. DGF rate was 29.1% in the BMI ≥ 30 and 30.7% in the BMI < 30 group (P = 0.41). On the other hand, 30 days readmission rate also did not show a significant difference between the BMI ≥ 30 and BMI < 30 allograft recipients (37 vs. 33.8%, P = 0.46). The mean overall costs of transplantation in the BMI ≥ 30 group was $254,395, and it was $256,029 in the BMI < 30 group (P = 0.84). CONCLUSION: Our study shows that the outcomes of renal allograft transplant were comparable between recipients with BMI ≥ 30 and BMI < 30 in terms of DGF, LOS, 30 days readmission, acute rejection rate, and survival rates, and BMI should not be a single independent criterion for decision making to select an optimal recipient.
Authors: Annemarie Weissenbacher; Maximilian Jara; Hanno Ulmer; Matthias Biebl; Claudia Bösmüller; Stefan Schneeberger; Gert Mayer; Johann Pratschke; Robert Öllinger Journal: Transplantation Date: 2012-03-15 Impact factor: 4.939
Authors: Juliane Liese; Nils Bottner; Stefan Büttner; Alexander Reinisch; Guido Woeste; Markus Wortmann; Ingeborg A Hauser; Wolf Otto Bechstein; Frank Ulrich Journal: Langenbecks Arch Surg Date: 2017-05-10 Impact factor: 3.445
Authors: G Grosso; D Corona; A Mistretta; D Zerbo; N Sinagra; A Giaquinta; P Caglià; C Amodeo; A Leonardi; R Gula; P Veroux; M Veroux Journal: Transplant Proc Date: 2012-09 Impact factor: 1.066
Authors: Daniel Pieloch; Viktor Dombrovskiy; Adena J Osband; Jonathan Lebowitz; David A Laskow Journal: J Ren Nutr Date: 2013-09-23 Impact factor: 3.655
Authors: Dorry L Segev; Christopher E Simpkins; Richard E Thompson; Jayme E Locke; Daniel S Warren; Robert A Montgomery Journal: J Am Soc Nephrol Date: 2007-12-19 Impact factor: 10.121
Authors: David W Johnson; Nicole M Isbel; Allison M Brown; Troy D Kay; Kirsten Franzen; Carmel M Hawley; Scott B Campbell; Darryl Wall; Anthony Griffin; David L Nicol Journal: Transplantation Date: 2002-09-15 Impact factor: 4.939